A patient is brought to the OPD by his wife, complaining about difficulty expressing emotions and not participating in daily activities. On examination, resting tremors and rigidity are noted. Given the possible diagnosis, which part of the brain is affected in this patient?

Correct Answer: C. Basal ganglia

The clinical triad presented—difficulty expressing emotions (affective blunting/apathy), reduced participation in daily activities (akinesia), resting tremor, and rigidity—is pathognomonic for Parkinson's disease (PD), which results from degeneration of dopaminergic neurons in the substantia nigra pars compacta, a key component of the basal ganglia. The basal ganglia circuit (substantia nigra → putamen/caudate → globus pallidus → thalamus → motor cortex) is responsible for motor planning, movement initiation, and emotional expression. Loss of dopamine in PD causes: (1) resting tremor (4–6 Hz "pill-rolling") due to unopposed activity of indirect pathway; (2) rigidity ("lead-pipe" or "cogwheel") from loss of dopaminergic inhibition of thalamic relay; (3) bradykinesia/akinesia from impaired movement initiation; and (4) apathy and affective blunting from dopamine depletion in mesolimbic/mesocortical pathways. In Indian clinical practice, PD is increasingly recognized in the elderly population, and the diagnosis is clinical (no single diagnostic test). The basal ganglia are the only structure among the options whose pathology explains all four cardinal features simultaneously. Dopamine replacement therapy (levodopa + carbidopa, per Indian DOC guidelines) is the mainstay of treatment, confirming the dopaminergic basis of the disorder.

Why the other options are wrong

A. Hippocampus — The hippocampus is critical for memory consolidation and spatial navigation, not motor control or emotional expression in the context of movement disorders. Hippocampal lesions cause amnesia and disorientation, not the resting tremor, rigidity, and bradykinesia seen here. This is an NBE trap pairing emotion with limbic structures, but the motor signs (tremor, rigidity) are the discriminating features pointing to basal ganglia pathology. B. Cerebellum — Cerebellar dysfunction causes intention tremor (present during goal-directed movement), ataxia, dysarthria, and nystagmus—not resting tremor or rigidity. While cerebellar lesions can affect emotional processing indirectly, they do not produce the classic triad of resting tremor, rigidity, and bradykinesia. The resting tremor is the key discriminator; cerebellar tremor only appears with movement. D. Premotor cortex — The premotor cortex is involved in motor planning and execution but not in the generation of resting tremor or the regulation of dopaminergic tone. Premotor cortex lesions cause contralateral weakness or loss of coordinated movement, not the combination of resting tremor, rigidity, and apathy. The presence of resting tremor specifically implicates subcortical basal ganglia circuits, not cortical motor areas.

High-Yield Facts

Mnemonics

TRAP for Parkinson's Disease Tremor (resting, 4–6 Hz), Rigidity (lead-pipe/cogwheel), Akinesia (bradykinesia), Postural instability. Use this to recall the four cardinal motor features of basal ganglia dysfunction in PD. Tremor Timing Memory Hook Resting tremor = Basal ganglia (Parkinson's). Intention tremor = Cerebellum. Postural tremor = Thyroid/anxiety. This 3-way split prevents confusion between PD and cerebellar disease.

NBE Trap

NBE pairs "difficulty expressing emotions" with limbic/cortical structures to lure students away from basal ganglia. However, the resting tremor and rigidity are the discriminating motor signs that unambiguously point to basal ganglia pathology; the emotional blunting is secondary to dopamine depletion in reward/motivation circuits, not primary limbic dysfunction.

Clinical Pearl

In Indian clinical practice, PD is often underdiagnosed in elderly patients who present with "slowing down" and apathy, mistaken for depression or dementia. The presence of resting tremor on examination is the key bedside sign that should trigger basal ganglia imaging and dopaminergic therapy, potentially reversing functional decline and improving quality of life in Indian geriatric populations.

_Reference: Robbins Ch. 28 (Nervous System); Harrison Ch. 428 (Parkinson's Disease); KD Tripathi Ch. 12 (Antiparkinsonian Drugs)_